Andrew John.William Heath, Director at Shield Therapeutics, holds 89.05K shares in Shield Therapeutics (Ticker: GB:STX). Most recently, Andrew John.William Heath Bought 3,334p shares of Shield Therapeutics on Jun 15, 2017 for an estimated value of 5.00K.